SUN-044 Gonadotropin Releasing Hormone (GnRH) Agonist Therapy Induces a Sustained Reduction in Plasma Testosterone Levels and Is Well Tolerated in Transwomen Veterans

Gender affirming hormone therapy (GAHT) is the mainstay of long-term management of transgender individuals. In transwomen, treatment with physiologic doses of estrogen alone is often insufficient to suppress testosterone to the desired level. Although GnRH agonist therapy is usually prescribed for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gondin, Lyan, Trejo, Jonathan, Pinkson, Sheila, chen, xi, Case, Emina, Wortham, Joy, koops, Maureen, Tripathy, Devjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209546/
http://dx.doi.org/10.1210/jendso/bvaa046.1575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209546/
http://dx.doi.org/10.1210/jendso/bvaa046.1575

Ejemplares similares